homepage-top-section

Xofluza is indicated to treat acute uncomplicated influenza in healthy children aged five to less than 12 years with symptoms for not over 48 hours. The regulatory approval

The new fully synthetic fluorocycline intravenous antibiotic, xerava has been developed to use as a first-line empiric monotherapy to treat multidrug resistance (MDR) infections, such as MDR Gram-negative

The regulatory indicated the healthcare providers to use the vaccine as intradermal injection for people aged 18 years and above, who are at elevated risk for monkeypox infection.

X-Chem will use the DEL services platform along with a group of new diverse lead- and drug-like small molecule compounds to help expedite the hits’ discovery and to

Kingray Capital, TigerYeah Capital, Morningside Venture Capital, and Trinity Innovation Fund joined the Series Pre-A funding, while FountainBridge Capital participated as the angel investor. Epigenic will utilise the

This drug is intended for the treatment of hallucinations and delusions related with Alzheimer’s disease psychosis (ADP). The CRL showed that the FDA has finished review of the

Vixarelimab has been designed to target oncostatin M receptor beta (OSMRβ) that mediates the interleukin-31 (IL-31) and oncostatin M (OSM) signalling. IL-31 and OSM are two important cytokines

Under the collaboration, the company will partner with the MD Anderson scientists on preclinical trials for further validating TransCode’s RNA-targeted oncology therapy and diagnostic candidates. They will also

Omidubicel is an advanced NAM-enabled stem cell therapy candidate which is being developed as a potential life-saving allogeneic hematopoietic stem cell (bone marrow) transplant solution for blood cancer